ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In a study conducted on 43 CML patients, Goh et al. demonstrated that dPCR could successfully detect BCR-ABL1 transcripts in qRT-PCR negative samples (24 out of 32) [41], suggesting the potential use of dPCR as highly sensitive approach in CML management.